144 related articles for article (PubMed ID: 2829753)
1. Heterogeneous distribution of lipoxygenase products in psoriatic skin lesions.
Fogh K; Kiil J; Herlin T; Ternowitz T; Kragballe K
Arch Dermatol Res; 1987; 279(8):504-11. PubMed ID: 2829753
[TBL] [Abstract][Full Text] [Related]
2. In vitro synthesis of 12-hydroxy-eicosatetraenoic acid is increased in uninvolved psoriatic epidermis.
Kragballe K; Desjarlais L; Duell EA; Voorhees JJ
J Invest Dermatol; 1986 Jul; 87(1):47-52. PubMed ID: 3088130
[TBL] [Abstract][Full Text] [Related]
3. Biosynthesis of lipoxygenase products by enzyme preparations from normal and psoriatic skin.
Ziboh VA; Casebolt TL; Marcelo CL; Voorhees JJ
J Invest Dermatol; 1984 Dec; 83(6):426-30. PubMed ID: 6094672
[TBL] [Abstract][Full Text] [Related]
4. Selective decrease of 15-hydroxyeicosatetraenoic acid (15-HETE) formation in uninvolved psoriatic dermis.
Kragballe K; Duell EA; Voorhees JJ
Arch Dermatol; 1986 Aug; 122(8):877-80. PubMed ID: 3090943
[TBL] [Abstract][Full Text] [Related]
5. Eicosanoids in acute and chronic psoriatic lesions: leukotriene B4, but not 12-hydroxy-eicosatetraenoic acid, is present in biologically active amounts in acute guttate lesions.
Fogh K; Herlin T; Kragballe K
J Invest Dermatol; 1989 Jun; 92(6):837-41. PubMed ID: 2542417
[TBL] [Abstract][Full Text] [Related]
6. Lipoxygenase products of arachidonic acid in human inflamed skin.
Black AK; Barr RM; Wong E; Brain S; Greaves MW; Dickinson R; Shroot B; Hensby CN
Br J Clin Pharmacol; 1985 Sep; 20(3):185-90. PubMed ID: 2994700
[TBL] [Abstract][Full Text] [Related]
7. Effect of dithranol treatment on arachidonic acid and its lipoxygenase products in psoriasis.
Barr RM; Wong E; Cunningham FM; Mallet AI; Greaves MW
Arch Dermatol Res; 1989; 280(8):474-6. PubMed ID: 2537608
[TBL] [Abstract][Full Text] [Related]
8. The chemokinetic response of psoriatic and normal polymorphonuclear leukocytes to arachidonic acid lipoxygenase products.
Cunningham FM; Wong E; Woollard PM; Greaves MW
Arch Dermatol Res; 1986; 278(4):270-3. PubMed ID: 3017241
[TBL] [Abstract][Full Text] [Related]
9. Identification of chemotactic lipoxygenase products of arachidonate metabolism in psoriatic skin.
Grabbe J; Czarnetzki BM; Rosenbach T; Mardin M
J Invest Dermatol; 1984 May; 82(5):477-9. PubMed ID: 6096449
[TBL] [Abstract][Full Text] [Related]
10. Reduction of lipoxygenase products in psoriatic skin homogenates by QA 208-199.
Schnyder J; Hunziker T; Strasser M; Richardson B; Krebs A
Arch Dermatol Res; 1986; 278(6):494-6. PubMed ID: 3024587
[No Abstract] [Full Text] [Related]
11. Conversion of linoleic acid and arachidonic acid by skin epidermal lipoxygenases.
Nugteren DH; Kivits GA
Biochim Biophys Acta; 1987 Sep; 921(1):135-41. PubMed ID: 3113487
[TBL] [Abstract][Full Text] [Related]
12. Modulation of eicosanoid formation by lesional skin of psoriasis: an ex vivo skin model.
Fogh K; Iversen L; Herlin T; Kragballe K
Acta Derm Venereol; 1993 Jun; 73(3):191-3. PubMed ID: 8105616
[TBL] [Abstract][Full Text] [Related]
13. Cutaneous responses to 12-hydroxy-5,8,10,14-eicosatetraenoic acid (12-HETE) and 5,12-dihydroxyeicosatetraenoic acid (leukotriene B4) in psoriasis and normal human skin.
Dowd PM; Black AK; Woollard PW; Greaves MW
Arch Dermatol Res; 1987; 279(7):427-34. PubMed ID: 2829751
[TBL] [Abstract][Full Text] [Related]
14. Dermis-derived 15-hydroxy-eicosatetraenoic acid inhibits epidermal 12-lipoxygenase activity.
Kragballe K; Pinnamaneni G; Desjarlais L; Duell EA; Voorhees JJ
J Invest Dermatol; 1986 Oct; 87(4):494-8. PubMed ID: 3093592
[TBL] [Abstract][Full Text] [Related]
15. Changes in lipoxygenase products from synovial fluid in carrageenan induced arthritis in dogs.
Herlin T; Fogh K; Ewald H; Hansen ES; Knudsen VE; Holm I; Kragballe K; Bunger C
APMIS; 1988 Jul; 96(7):601-4. PubMed ID: 2841956
[TBL] [Abstract][Full Text] [Related]
16. Intracellular retention of the 5-lipoxygenase pathway product, leukotriene B4, by human neutrophils activated with unopsonized zymosan.
Williams JD; Lee TH; Lewis RA; Austen F
J Immunol; 1985 Apr; 134(4):2624-30. PubMed ID: 2982947
[TBL] [Abstract][Full Text] [Related]
17. The effect of etretinate on the cyclo-oxygenase and lipoxygenase products of arachidonic acid metabolism in psoriatic skin.
Wong E; Barr RM; Brain SD; Greaves MW; Olins LA; Mallet AI
Br J Clin Pharmacol; 1984 Oct; 18(4):523-7. PubMed ID: 6091710
[TBL] [Abstract][Full Text] [Related]
18. Topical steroid treatment reduces arachidonic acid and leukotriene B4 in lesional skin of psoriasis.
Wong E; Barr RM; Cunningham FM; Mistry K; Woollard PM; Mallet AI; Greaves MW
Br J Clin Pharmacol; 1986 Dec; 22(6):627-32. PubMed ID: 3032226
[TBL] [Abstract][Full Text] [Related]
19. Inhibition of ionophore-stimulated leukotriene B4 production in human leucocytes by monohydroxy fatty acids.
Camp RD; Fincham NJ
Br J Pharmacol; 1985 Aug; 85(4):837-41. PubMed ID: 2994785
[TBL] [Abstract][Full Text] [Related]
20. Leukotrienes C4 and D4 in psoriatic skin lesions.
Brain SD; Camp RD; Black AK; Dowd PM; Greaves MW; Ford-Hutchinson AW; Charleson S
Prostaglandins; 1985 Apr; 29(4):611-9. PubMed ID: 2988023
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
